Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,858	2,219	2,756	5,430	4,732	-
Market Cap Growth	21.70%	-19.50%	-49.24%	14.74%	-	-
Enterprise Value	925	1,193	1,844	4,599	4,525	-74
PE Ratio	-	-16.74	-9.53	-14.65	-24.16	-
PS Ratio	5.15	5.87	45.24	104.73	197180.98	-
PB Ratio	2.03	2.26	3.76	6.57	19.27	-
P/FCF Ratio	-15.94	-12.13	-104.30	-48.02	-42.22	-
P/OCF Ratio	-19.39	-14.87	122.34	-81.94	-49.43	-
EV/Sales Ratio	2.56	3.16	30.27	88.71	188561.52	-4107.89
EV/EBITDA Ratio	-15.68	-10.73	-6.79	-12.66	-23.84	0.99
EV/EBIT Ratio	-13.23	-9.09	-6.46	-12.41	-23.26	0.94
EV/FCF Ratio	-10.43	-6.52	-69.79	-40.67	-40.37	0.87
Debt / Equity Ratio	0.18	0.18	0.24	0.18	0.44	-0.16
Debt / EBITDA Ratio	-1.49	-1.55	-0.66	-0.41	-0.57	-0.42
Debt / FCF Ratio	-0.99	-0.94	-6.77	-1.31	-0.96	-0.37
Quick Ratio	5.88	5.83	4.88	5.99	3.07	3.61
Current Ratio	5.99	5.89	4.89	5.96	3.01	3.25
Asset Turnover	0.26	0.28	0.04	0.05	0	0
Return on Equity (ROE)	-15.50%	-15.90%	-37.60%	-55.90%	-83.50%	57.20%
Return on Assets (ROA)	-9.90%	-9.80%	-20.80%	-35.20%	-57.90%	-56.40%
Return on Capital (ROIC)	-16.80%	-15.29%	-37.09%	-40.28%	-37.59%	44.24%
Earnings Yield	-7.25%	-5.97%	-10.49%	-6.83%	-4.14%	-
FCF Yield	-9.11%	-8.25%	-0.96%	-2.08%	-2.37%	-
Buyback Yield / Dilution	-13.04%	-10.19%	-9.01%	-37.43%	-621.24%	-123.90%
Total Shareholder Return	-13.04%	-10.19%	-9.01%	-37.43%	-621.24%	-123.90%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).